Study #2021-0789
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
MD Anderson Study Status
Enrolling
Treatment Agent
Radiation therapy
Description
This phase II trial tests whether hypofractionated radiation works to treat patients with Merkel cell carcinoma. Radiation therapy uses high energy radio waves to kill cancer cells and shrink tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may be more convenient for patients and less immunosuppressive.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Merkel Cell Carcinoma
Study phase:
Phase II
Physician name:
Devarati Mitra
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.